[1] MULLER S, WITTE F, STANDER S. Pruritus in atopic dermatitis-comparative evaluation of novel treatment approaches. Dermatologie (Heidelb). 2022;73(7): 538-549.
[2] GATMAITAN JG, LEE JH. Challenges and Future Trends in Atopic Dermatitis. Int J Mol Sci. 2023;24(14):11380.
[3] XUE Y, BAO W, ZHOU J, et al. Global Burden, Incidence and Disability-Adjusted Life-Years for Dermatitis: A Systematic Analysis Combined With Socioeconomic Development Status, 1990-2019. Front Cell Infect Microbiol. 2022;12:861053.
[4] GUTTMAN-YASSK E, RENERT-YUVAL Y, BRUNNER PM. Atopic dermatitis. Lancet. 2025;405(10478):583-596.
[5] SON SW, LEE JH, AHN J, et al. Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea. Ann Dermatol. 2022; 34(6):419-430.
[6] 张国山,刘密,章海凤,等.艾灸温通、温补效应之间的关系[J]. 时珍国医国药,2013,24(10):2468-2469.
[7] 鲁熹. 艾灸疗法改善慢性湿疹瘙痒症状的临床疗效观察[D]. 成都:成都中医药大学,2022.
[8] 伍娅欣. 电针结合艾灸治疗慢性湿疹的临床观察及其对血清IgE的影响[D]. 泸州:西南医科大学,2019.
[9] 毛钟莹. 毫火针结合艾灸治疗脾虚湿蕴型慢性湿疹的临床观察[D]. 广州:广州中医药大学,2021.
[10] AIERKEN K, LUO Y, MAIWULANJIANG M, et al. The Suppressive Effect of Mamiran Cream on Atopic Dermatitis-Like Skin Lesions In Vivo. Evid Based Complement Alternat Med. 2021;2021:2854238.
[11] 林建红, 陈海军, 朱思颐. EGCG调节TLR4/MyD88/NF-κB信号通路对特应性皮炎大鼠Th1/Th2平衡的影响[J]. 西部医学,2024,36(2):211-216.
[12] 苗明三, 田硕, 白明. 湿疹动物模型制备规范(草案)[J]. 中国实验方剂学杂志, 2017,23(24):6-10.
[13] 赵辨. 湿疹面积及严重度指数评分法[J]. 中华皮肤科杂志,2004(1):7-8.
[14] CHOPRE R, SILVERBERG JI. Assessing the severity of atopic dermatitis in clinical trials and practice. Clin Dermatol. 2018;36(5):606-615.
[15] 汪秀梅. 针灸对湿热蕴肤证、血虚风燥证、脾虚湿蕴证三种湿疹模型表皮通透屏障功能影响的研究[D]. 乌鲁木齐:新疆医科大学, 2021.
[16] 余曙光,徐斌. 实验针灸学[M]. 北京:人民卫生出版社, 2016.
[17] 于燕艳,刘娟,杨越,等.艾灸抑制NLRP3/Caspase-1通路介导的细胞焦亡减轻脑缺血再灌注损伤[J].中国组织工程研究,2024,28(34):5473-5479.
[18] PATRICK GJ, ARCHER NK, MILLER LS. Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis. J Invest Dermatol. 2021;141(2):274-284.
[19] BIEBER T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022;21(1):21-40.
[20] MOYLE M, CEVIKBAS F, HARDEN JL, et al. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches. Exp Dermatol. 2019;28(7):756-768.
[21] XIN P, XU X, DENG C, et al. The role of JAK/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol. 2020;80:106210.
[22] AGASHE RP, LIPPMAN SM, KURZROCK R. JAK: Not Just Another Kinase. Mol Cancer Ther. 2022;21(12):1757-1764.
[23] 李文婕, 周萌, 苏银妹, 等. 周萌从脾论治湿疹经验[J]. 江西中医药,2019, 50(10):31-32.
[24] 刁庆春, 刘毅. 湿疹(湿疮)中医诊疗专家共识[J]. 中国中西医结合皮肤性病学杂志,2021,20(5):517-521.
[25] 严格,王怡,杜欣冉,等.“血虚风燥证”皮肤疾病生物学基础研究进展[J].皮肤科学通报,2024,41(3):229-235.
[26] HAMIDI H, IVASKA J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533-548.
[27] XU YH, LI ZL, QIU SF. IFN-gamma Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin beta3-Mediated NF-kappaB Signaling. Transl Oncol. 2018;11(1):182-192.
[28] THOMPSON EE, PAN L, OSTROVNAYA I, et al. Integrin beta 3 genotype influences asthma and allergy phenotypes in the first 6 years of life. J Allergy Clin Immunol. 2007;119(6):1423-1429.
[29] ARTEAGA-BADILLO DA, PORTILLO-REYES J, VARGAS-MENDOZA N, et al. Asthma: New Integrative Treatment Strategies for the Next Decades. Medicina (Kaunas), 2020,56(9).
[30] MACIAG MC, PHIPATANAKUL W. Preventing the development of asthma: stopping the allergic march. Curr Opin Allergy Clin Immunol. 2019;19(2):161-168.
[31] 李淑芬, 李希. β1,4半乳糖基转移酶的生物学功能研究进展[J]. 生命的化学, 2016,36(5):589-595.
[32] ASANO M, NAKAE S, KOTANI N, et al. Impaired selectin-ligand biosynthesis and reduced inflammatory responses in beta-1,4-galactosyltransferase-I-deficient mice. Blood. 2003;102(5):1678-1685.
[33] HAN Y, ZHOU X, JI Y, et al. Expression of beta-1,4-galactosyltransferase-I affects cellular adhesion in human peripheral blood CD4+ T cells. Cell Immunol. 2010; 262(1):11-17.
[34] MOHAMMAD S, KARIM MR, IQBAL S, et al. Atopic dermatitis: Pathophysiology, microbiota, and metabolome-A comprehensive review. Microbiol Res. 2024; 281:127595.
[35] LAMPSON BL, RAMΊREZ AS, BARO M, et al. Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB. Cell. 2024;187(9):2209-2223.e16.
[36] LAWRENCE T, GILROY DW, COLVILLE-NASH PR, et al. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med. 2001;7(12):1291-1297.
[37] POLADIAN N, ORUJYAN D, NARINYAN W, et al. Role of NF-κB during Mycobacterium tuberculosis Infection. Int J Mol Sci. 2023;24(2):1772.
[38] LIU T, ZHANG L, JOO D, et al. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.
[39] LONG H, ZHANG G, WANG L, et al. Eosinophilic Skin Diseases: A Comprehensive Review. Clin Rev Allergy Immunol. 2016;50(2):189-213.
[40] DU X, SHI H, LIU X, et al. Genetic support for the causal association between 91 circulating inflammatory proteins and atopic dermatitis: A two-sample Mendelian randomization trial. Skin Res Technol. 2024;30(8):e13872.
[41] KO KI, MERLET JJ, DERGARABEDIAN BP, et al. NF-kappaB perturbation reveals unique immunomodulatory functions in Prx1(+) fibroblasts that promote development of atopic dermatitis. Sci Transl Med. 2022;14(630):j324.
[42] LIU W, SONG W, LUO Y, et al. Angelica Yinzi alleviates 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs/NF-kB signaling pathway. Saudi Pharm J. 2022; 30(10):1426-1434.
[43] LI X, LU C, DU W, et al. Development of new dehydrocostuslactone derivatives for treatment of atopic dermatitis via inhibition of the NF-kappaB signaling pathway. RSC Med Chem. 2024;15(8):2773-2784.
[44] ROY T, BOATENG ST, UDDIN MB, et al. The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds. Cells. 2023;12(12):1671.
[45] BUERGER C. Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target. Front Immunol. 2018;9:2786.
[46] HOU T, SUN X, ZHU J, et al. IL-37 Ameliorating Allergic Inflammation in Atopic Dermatitis Through Regulating Microbiota and AMPK-mTOR Signaling Pathway-Modulated Autophagy Mechanism. Front Immunol. 2020;11:752.
[47] KRISHNAMURTHY P, DA-SILVA-ARNOLD S, TURNER MJ, et al. Poly-ADP ribose polymerase-14 limits severity of allergic skin disease. Immunology. 2017;152(3): 451-461.
[48] YANG X, MAO Z, HUANG Y, et al. Reductively modified albumin attenuates DSS-Induced mouse colitis through rebalancing systemic redox state. Redox Biol. 2021;41:101881.
[49] INOUE M, NAKASHIMA R, ENOMOTO M, et al. Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis. Nat Commun. 2018;9(1):5116.
[50] SIMONETTI O, BACCHETTI T, FERRETTI G, et al. Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis. Antioxidants (Basel). 2021;10(5):697.
[51] WANG Y, LU H, CHENG L, et al. Targeting mitochondrial dysfunction in atopic dermatitis with trilinolein: A triacylglycerol from the medicinal plant Cannabis fructus. Phytomedicinel. 2024;132(2024):155856.
[52] JI H, LI XK. Oxidative Stress in Atopic Dermatitis. Oxid Med Cell Longev. 2016; 2016:2721469.
[53] SIVARANJANI N, RAO SV, RAJEEV G. Role of reactive oxygen species and antioxidants in atopic dermatitis. J Clin Diagn Res. 2013;7(12):2683-2685.
[54] CHEN X, ZHANG Y, PEI J, et al. Phellopterin alleviates atopic dermatitis-like inflammation and suppresses IL-4-induced STAT3 activation in keratinocytes. Int Immunopharmacol. 2022;112:109270.
[55] HAGIYAMA M, INOUE T, FURUNO T, et al. Increased expression of cell adhesion molecule 1 by mast cells as a cause of enhanced nerve-mast cell interaction in a hapten-induced mouse model of atopic dermatitis. Br J Dermatol. 2013; 168(4):771-778.
[56] OH JE, KIM SN. Anti-Inflammatory Effects of Acupuncture at ST36 Point: A Literature Review in Animal Studies. Front Immunol. 2021;12:813748.
[57] ZHAI L, WAN X, WU R, et al. Linc-RAM promotes muscle cell differentiation via regulating glycogen phosphorylase activity. Cell Regen. 2022;11(1):8.
[58] ARRIZABALAGA O, LACERDA HM, ZUBIAGA AM, et al. Rac1 protein regulates glycogen phosphorylase activation and controls interleukin (IL)-2-dependent T cell proliferation. J Biol Chem. 2012;287(15):11878-11890.
[59] SIERRA A, OLIVEIRA RA, SILVA ED, et al. Association Between Hematological Parameters and Iron Metabolism Response After Marathon Race and ACTN3 Genotype. Front Physiol. 2019;10:697.
|